219 related articles for article (PubMed ID: 12698871)
1. Mucosal T cells as a target for treatment of IBD.
Watanabe M; Yamazaki M; Kanai T
J Gastroenterol; 2003 Mar; 38 Suppl 15():48-50. PubMed ID: 12698871
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
3. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice.
Okada E; Yamazaki M; Tanabe M; Takeuchi T; Nanno M; Oshima S; Okamoto R; Tsuchiya K; Nakamura T; Kanai T; Hibi T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G745-54. PubMed ID: 15550560
[TBL] [Abstract][Full Text] [Related]
4. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
5. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway.
Watanabe M; Yamazaki M; Okamoto R; Ohoka S; Araki A; Nakamura T; Kanai T
Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):119-23. PubMed ID: 14561163
[TBL] [Abstract][Full Text] [Related]
7. IL-15 protects intestinal epithelial cells.
Obermeier F; Hausmann M; Kellermeier S; Kiessling S; Strauch UG; Duitman E; Bulfone-Paus S; Herfarth H; Bock J; Dunger N; Stoeck M; Schölmerich J; Falk W; Rogler G
Eur J Immunol; 2006 Oct; 36(10):2691-9. PubMed ID: 16981178
[TBL] [Abstract][Full Text] [Related]
8. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model.
Westendorf AM; Bruder D; Hansen W; Buer J
Ann N Y Acad Sci; 2006 Aug; 1072():401-6. PubMed ID: 17057222
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes.
Watanabe M; Ueno Y; Yajima T; Iwao Y; Tsuchiya M; Ishikawa H; Aiso S; Hibi T; Ishii H
J Clin Invest; 1995 Jun; 95(6):2945-53. PubMed ID: 7769137
[TBL] [Abstract][Full Text] [Related]
10. Bacterial invasion induces interleukin-7 receptor expression in colonic epithelial cell line, T84.
Yamada K; Shimaoka M; Nagayama K; Hiroi T; Kiyono H; Honda T
Eur J Immunol; 1997 Dec; 27(12):3456-60. PubMed ID: 9464835
[TBL] [Abstract][Full Text] [Related]
11. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
12. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
[TBL] [Abstract][Full Text] [Related]
13. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
14. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
[TBL] [Abstract][Full Text] [Related]
15. Non-redundant role for IL-7R signaling for the survival of CD8+ memory T cells.
Carrio R; Rolle CE; Malek TR
Eur J Immunol; 2007 Nov; 37(11):3078-88. PubMed ID: 17935075
[TBL] [Abstract][Full Text] [Related]
16. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis.
Yamazaki M; Yajima T; Tanabe M; Fukui K; Okada E; Okamoto R; Oshima S; Nakamura T; Kanai T; Uehira M; Takeuchi T; Ishikawa H; Hibi T; Watanabe M
J Immunol; 2003 Aug; 171(3):1556-63. PubMed ID: 12874249
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
Gordon JN; Di Sabatino A; Macdonald TT
Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
[TBL] [Abstract][Full Text] [Related]
20. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
